CSL has received approval from the EC for Andembry (garadacimab) to prevent recurrent attacks of HAE in patients aged 12 ...

Home Healthcare Devices Market Aging Population, Chronic Disease Surge, and Technological Innovations Fuel Growth in Home Healthcare Device ...